|
1
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Guthrie GJ, Charles KA, Roxburgh CS,
Horgan PG, McMillan DC and Clarke SJ: The systemic
inflammation-based neutrophil-lymphocyte ratio: Experience in
patients with cancer. Crit Rev Oncol Hematol. 88:218–230.
2013.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Templeton AJ, McNamara MG, Šeruga B,
Vera-Badillo FE, Aneja P, Ocaña A, Leibowitz-Amit R, Sonpavde G,
Knox JJ, Tran B, et al: Prognostic role of neutrophil-to-lymphocyte
ratio in solid tumors: A systematic review and meta-analysis. J
Natl Cancer Inst. 106(dju124)2014.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Kao J, Gold KD, Zarrili G, Copel E,
Silverman AJ, Ramsaran SS, Yens D and Ryu S: Clinical predictors of
survival for patients with stage IV cancer referred to radiation
oncology. PLoS One. 10(e0124329)2015.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Zucker A, Tsai CJ, Loscalzo J, Calves P
and Kao J: The NEAT predictive model for survival in patients with
advanced cancer. Cancer Res Treat. 50:1433–1443. 2018.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Chow E, Abdolell M, Panzarella T, Harris
K, Bezjak A, Warde P and Tannock I: Predictive model for survival
in patients with advanced cancer. J Clin Oncol. 26:5863–5869.
2008.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Krishnan MS, Epstein-Peterson Z, Chen YH,
Tseng YD, Wright AA, Temel JS, Catalano P and Balboni TA:
Predicting life expectancy in patients with metastatic cancer
receiving palliative radiotherapy: The TEACHH model. Cancer.
120:134–141. 2014.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Kao J, Timmins J, Ozao-Choy J and Packer
S: Effects of combined sunitinib and extracranial stereotactic
radiotherapy on bone marrow hematopoiesis. Oncol Lett.
12:2139–2144. 2016.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Golden EB, Chhabra A, Chachoua A, Adams S,
Donach M, Fenton-Kerimian M, Friedman K, Ponzo F, Babb JS, Goldberg
J, et al: Local radiotherapy and granulocyte-macrophage
colony-stimulating factor to generate abscopal responses in
patients with metastatic solid tumours: A proof-of-principle trial.
Lancet Oncol. 16:795–803. 2015.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Azab B, Camacho-Rivera M and Taioli E:
Average values and racial differences of neutrophil lymphocyte
ratio among a nationally representative sample of United States
subjects. PLoS One. 9(e112361)2014.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Forget P, Khalifa C, Defour JP, Latinne D,
Van Pel MC and De Kock M: What is the normal value of the
neutrophil-to-lymphocyte ratio? BMC Res Notes.
10(12)2017.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Gomez DR, Blumenschein GR Jr, Lee JJ,
Hernandez M, Ye R, Camidge DR, Doebele RC, Skoulidis F, Gaspar LE,
Gibbons DL, et al: Local consolidative therapy versus maintenance
therapy or observation for patients with oligometastatic
non-small-cell lung cancer without progression after front-line
systemic therapy: A multicentre, randomised, controlled, phase 2
study. Lancet Oncol. 17:1672–1682. 2016.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Hong JC, Ayala-Peacock DN, Lee J,
Blackstock AW, Okunieff P, Sung MW, Weichselbaum RR, Kao J, Urbanic
JJ, Milano MT, et al: Classification for long-term survival in
oligometastatic patients treated with ablative radiotherapy: A
multi-institutional pooled analysis. PLoS One.
13(e0195149)2018.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Kitamura T, Qian BZ and Pollard JW: Immune
cell promotion of metastasis. Nat Rev Immunol. 15:73–86.
2015.PubMed/NCBI View
Article : Google Scholar
|
|
15
|
Coffelt SB, Wellenstein MD and de Visser
KE: Neutrophils in cancer: Neutral no more. Nat Rev Cancer.
16:431–446. 2016.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Nicolas-Avila JA, Adrover JM and Hidalgo
A: Neutrophils in homeostasis, immunity, and cancer. Immunity.
46:15–28. 2017.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Chen HM, Ma G, Gildener-Leapman N,
Eisenstein S, Coakley BA, Ozao J, Mandeli J, Divino C, Schwartz M,
Sung M, et al: Myeloid-derived suppressor cells as an immune
parameter in patients with concurrent sunitinib and stereotactic
body radiotherapy. Clin Cancer Res. 21:4073–4085. 2015.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Chowdhary M, Switchenko JM, Press RH,
Jhaveri J, Buchwald ZS, Blumenfeld PA, Marwaha G, Diaz A, Wang D,
Abrams RA, et al: Post-treatment neutrophil-to-lymphocyte ratio
predicts for overall survival in brain metastases treated with
stereotactic radiosurgery. J Neurooncol. 139:689–697.
2018.PubMed/NCBI View Article : Google Scholar
|
